(ASRT) Assertio Therapeutics - Performance -33.7% in 12m
Compare ASRT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-66.10%
#128 in Group
Rel. Strength 12m
17.58%
#6451 in Universe
Total Return 12m
-33.73%
#131 in Group
Total Return 5y
-75.92%
#126 in Group
12m Total Return: ASRT (-33.7%) vs XLV (0.9%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group (based on Performance, Valuations and Relative Strength)
| Symbol | 1m | 12m | 5y | P/E | P/B | Growth Rating |
|---|---|---|---|---|---|---|
| CPH TO Cipher Pharmaceuticals |
-12.0% | 59.2% | 2,125% | 12.84 | 2.36 | 90.59 |
| PBH NYSE Prestige Brand Holdings |
-2.69% | 13.1% | 176% | 20.90 | 2.41 | 88.84 |
| NVS NYSE Novartis |
7.17% | 15.1% | 93.0% | 19.67 | 5.18 | 67.99 |
| NOVN SW Novartis |
4.64% | 15.0% | 76.8% | 19.33 | 5.01 | 64.74 |
| RDY NYSE Dr. Reddy’s Laboratories |
-6.76% | -10.8% | 108% | 17.18 | 2.90 | 53.55 |
Performance Duell ASRT vs XLV
| Total Return (including Dividends) | ASRT | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -14.18% | 0.09% | -7.69% |
| 3 Months | -23.16% | 4.51% | -6.94% |
| 12 Months | -33.73% | 0.88% | 10.70% |
| 5 Years | -75.92% | 92.03% | 153.10% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #138 | -14.3% | -7.02% |
| 3 Month | #147 | -26.5% | -17.4% |
| 12 Month | #130 | -34.3% | -40.1% |
| 5 Years | #135 | -87.5% | -90.5% |
| Trend Score (consistency of price movement) | ASRT | XLV | S&P 500 |
| 1 Month | -76.8% | 8.1% | -96% |
| 3 Months | -82.2% | 81.6% | -21% |
| 12 Months | -43.5% | 23.2% | 91% |
| 5 Years | -42.9% | 90.5% | 84.5% |
FAQs
Does ASRT Assertio Therapeutics outperforms the market?
No,
over the last 12 months ASRT made -33.73%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.88%.
Over the last 3 months ASRT made -23.16%, while XLV made 4.51%.
Over the last 3 months ASRT made -23.16%, while XLV made 4.51%.
Performance Comparison ASRT vs Indeces and Sectors
ASRT vs. Indices ASRT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -5.34% | -6.49% | -42.4% | -44.4% |
| US NASDAQ 100 | QQQ | -5.15% | -3.31% | -43.4% | -43.6% |
| US Dow Jones Industrial 30 | DIA | -4.61% | -7.49% | -42.1% | -42.0% |
| German DAX 40 | DAX | -7.61% | -16.4% | -65.0% | -61.2% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.9% | -16.9% | -66.9% | -49.1% |
| Hongkong Hang Seng | HSI | -6.75% | -21.1% | -57.2% | -48.2% |
| India NIFTY 50 | INDA | -7.27% | -12.8% | -26.5% | -30.9% |
| Brasil Bovespa | EWZ | -11.7% | -12.2% | -31.9% | -19.9% |
ASRT vs. Sectors ASRT is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -3.92% | -5.89% | -52.4% | -55.7% |
| Consumer Discretionary | XLY | -3.26% | -0.83% | -44.5% | -44.0% |
| Consumer Staples | XLP | -3.58% | -12.8% | -37.3% | -41.9% |
| Energy | XLE | -10.3% | -13.8% | -47.2% | -35.3% |
| Financial | XLF | -6.40% | -7.85% | -50.2% | -54.4% |
| Health Care | XLV | -4.71% | -14.3% | -34.7% | -34.6% |
| Industrial | XLI | -5.30% | -9.51% | -42.5% | -42.8% |
| Materials | XLB | -5.52% | -9.87% | -34.6% | -30.2% |
| Real Estate | XLRE | -5.22% | -12.7% | -34.8% | -43.6% |
| Technology | XLK | -5.52% | -3.33% | -39.5% | -36.9% |
| Utilities | XLU | -9.66% | -13.9% | -42.9% | -62.1% |
| Aerospace & Defense | XAR | -8.13% | -10.0% | -48.3% | -52.3% |
| Biotech | XBI | -7.43% | -9.50% | -27.8% | -26.1% |
| Homebuilder | XHB | -3.33% | -5.57% | -22.9% | -27.2% |
| Retail | XRT | -1.75% | 0.73% | -31.8% | -24.9% |